<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Embelia ribes is being used in Indian traditional herbal medicine for the treatment of <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> and as brain tonic </plain></SENT>
<SENT sid="1" pm="."><plain>The present study was designed to investigate the protective effects of embelin from E. ribes on global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-induced brain injury in rats </plain></SENT>
<SENT sid="2" pm="."><plain>Transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by occluding bilateral common carotid arteries for 30 min followed by 24-h reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological functions were measured using sensorimotor tests </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>/reperfusion-induced neuronal injury was assessed by cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> area, biochemical and histopathological examination </plain></SENT>
<SENT sid="5" pm="."><plain>Pretreatment of embelin (25 and 50 mg/kg, p.o.) significantly <z:mp ids='MP_0001399'>increased locomotor activity</z:mp> and hanging latency time and decreased beam walking latency when compared with ischemic control </plain></SENT>
<SENT sid="6" pm="."><plain>The treatment also reduced significantly the <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and increased the total <z:chebi fb="0" ids="29256">thiol</z:chebi> content and <z:chebi fb="0" ids="16856">glutathione</z:chebi>-S-transferase activity in brain homogenates </plain></SENT>
<SENT sid="7" pm="."><plain>The decreased <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> area in embelin-treated groups and histopathological observations confirmed the above findings </plain></SENT>
<SENT sid="8" pm="."><plain>These observations suggested that embelin is a neuroprotective agent and may prove to be useful adjunct in the treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>